232 related articles for article (PubMed ID: 28818703)
1. Traceable PEO-poly(ester) micelles for breast cancer targeting: The effect of core structure and targeting peptide on micellar tumor accumulation.
Garg SM; Paiva IM; Vakili MR; Soudy R; Agopsowicz K; Soleimani AH; Hitt M; Kaur K; Lavasanifar A
Biomaterials; 2017 Nov; 144():17-29. PubMed ID: 28818703
[TBL] [Abstract][Full Text] [Related]
2. Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel.
Shahin M; Ahmed S; Kaur K; Lavasanifar A
Biomaterials; 2011 Aug; 32(22):5123-33. PubMed ID: 21501865
[TBL] [Abstract][Full Text] [Related]
3. The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells.
Mahmud A; Lavasanifar A
Colloids Surf B Biointerfaces; 2005 Oct; 45(2):82-9. PubMed ID: 16144761
[TBL] [Abstract][Full Text] [Related]
4. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery.
Mahmud A; Xiong XB; Lavasanifar A
Eur J Pharm Biopharm; 2008 Aug; 69(3):923-34. PubMed ID: 18430550
[TBL] [Abstract][Full Text] [Related]
5. Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.
Mahmud A; Patel S; Molavi O; Choi P; Samuel J; Lavasanifar A
Biomacromolecules; 2009 Mar; 10(3):471-8. PubMed ID: 19175305
[TBL] [Abstract][Full Text] [Related]
6. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
Biomacromolecules; 2007 Mar; 8(3):874-84. PubMed ID: 17315946
[TBL] [Abstract][Full Text] [Related]
7. Polymeric micelles based on poly(ethylene oxide) and α-carbon substituted poly(ɛ-caprolactone): An in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity.
Garg SM; Vakili MR; Lavasanifar A
Colloids Surf B Biointerfaces; 2015 Aug; 132():161-70. PubMed ID: 26037706
[TBL] [Abstract][Full Text] [Related]
8. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
Molavi O; Ma Z; Mahmud A; Alshamsan A; Samuel J; Lai R; Kwon GS; Lavasanifar A
Int J Pharm; 2008 Jan; 347(1-2):118-27. PubMed ID: 17681440
[TBL] [Abstract][Full Text] [Related]
9. Peptide modified polymeric micelles specific for breast cancer cells.
Mathews AS; Ahmed S; Shahin M; Lavasanifar A; Kaur K
Bioconjug Chem; 2013 Apr; 24(4):560-70. PubMed ID: 23514428
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
Shenoy DB; Amiji MM
Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
[TBL] [Abstract][Full Text] [Related]
11. Development of Traceable Rituximab-Modified PEO-Polyester Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell Lymphoma.
Saqr A; Vakili MR; Huang YH; Lai R; Lavasanifar A
ACS Omega; 2019 Nov; 4(20):18867-18879. PubMed ID: 31737848
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the self assembly of methoxy poly(ethylene oxide)-block-poly(α-benzyl carboxylate-ε-caprolactone) for the solubilization and in vivo delivery of valspodar.
Binkhathlan Z; Elhasi S; Brocks DR; Lavasanifar A
Curr Drug Deliv; 2012 Mar; 9(2):164-71. PubMed ID: 22283648
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
Xiong XB; Ma Z; Lai R; Lavasanifar A
Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
[TBL] [Abstract][Full Text] [Related]
14. Polymeric micelles for pH-responsive delivery of cisplatin.
Shahin M; Safaei-Nikouei N; Lavasanifar A
J Drug Target; 2014 Aug; 22(7):629-37. PubMed ID: 24878378
[TBL] [Abstract][Full Text] [Related]
15. Delivery and Biodistribution of Traceable Polymeric Micellar Diclofenac in the Rat.
Al-Lawati H; Vakili MR; Lavasanifar A; Ahmed S; Jamali F
J Pharm Sci; 2019 Aug; 108(8):2698-2707. PubMed ID: 30905704
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells.
Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
Pharm Res; 2008 Nov; 25(11):2555-66. PubMed ID: 18636321
[TBL] [Abstract][Full Text] [Related]
17. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
18. Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles.
Elhasi S; Astaneh R; Lavasanifar A
Eur J Pharm Biopharm; 2007 Mar; 65(3):406-13. PubMed ID: 17291732
[TBL] [Abstract][Full Text] [Related]
19. Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery.
Hu Z; Luo F; Pan Y; Hou C; Ren L; Chen J; Wang J; Zhang Y
J Biomed Mater Res A; 2008 Jun; 85(3):797-807. PubMed ID: 17896765
[TBL] [Abstract][Full Text] [Related]
20. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
Aliabadi HM; Mahmud A; Sharifabadi AD; Lavasanifar A
J Control Release; 2005 May; 104(2):301-11. PubMed ID: 15907581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]